the controlled drug legislation in these jurisdictions requires drug scheduling decisions to follow an evidence based process where the harms of the drug are assessed and reviewed so that an appropriate legal status can be assigned since many designer drugs sold in recent years have had little or no published research that could help inform such a decision they have been widely sold as legal highs often for months before sufficient evidence accumulates to justify placing them on the controlled drug schedules this situation has been deemed to be undesirable as every time a designer drug has been banned novel compounds with similar effects have been quickly developed and brought to market often with worse health consequences reported than the original compound the temporary class drug status has been developed to circumvent the evidential requirements and allow drugs to be banned temporarily as soon as they are deemed by authorities to be causing harm to individuals or society the temporary ban lasts for a period of 1 year after which the drug would in theory be made legal again if sufficient evidence to ban it permanently had not been forthcoming during the period of the temporary ban the temporary class